Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	olfactory receptor activity	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	1.54e-65	431	304	81	GO:0004984
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P ADGRD1 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	1.93e-45	884	304	86	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	FCRL2 OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 PDGFRA OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 FCRL3 OR5AC2 HMCN2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 KIR2DL4 OR5K1 OR7A10 OR7A2P UNC5D ADGRD1 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 SEMA4D OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 GRIA3 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 LEPR OR4K14 OR10A3 OR3A1 OR6V1 UNC5CL OR5H8 OR10A6 OR2A25 FCRL5 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	5.02e-40	1353	304	97	GO:0004888
GeneOntologyMolecularFunction	odorant binding	OR5T1 OR5M10 OR5AC1 OR5M1 OR5AK2 OR8B3 OR5J2 OR5AC2 OR1K1 OR5K2 OR5K1 OR5P2 VN1R2 OR5P3 OR5B3 OR5G3 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR5AR1 OR5H8 OR2A25 OR8B2	2.02e-23	127	304	27	GO:0005549
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-19 ERVK-25 ERVK-24	1.85e-05	37	304	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-19 ERVK-25 ERVK-24	2.17e-05	38	304	6	GO:0070001
GeneOntologyMolecularFunction	chemorepellent activity	SEMA3G SLIT2 SEMA4D SEMA3C SEMA4G	6.96e-05	29	304	5	GO:0045499
GeneOntologyMolecularFunction	dynein intermediate chain binding	SPTBN5 DNAH10 DYNLT3 DNAH1 DYNLT4	2.31e-04	37	304	5	GO:0045505
GeneOntologyMolecularFunction	semaphorin receptor binding	SEMA3G SEMA4D SEMA3C SEMA4G	3.71e-04	23	304	4	GO:0030215
GeneOntologyMolecularFunction	cysteine-type exopeptidase activity	SCRN1 MINDY2 MINDY1	3.87e-04	10	304	3	GO:0070004
GeneOntologyMolecularFunction	growth hormone receptor binding	TYK2 JAK1 JAK3	3.87e-04	10	304	3	GO:0005131
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	6.86e-04	3	304	2	GO:0018858
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	8.52e-67	432	302	81	GO:0050911
GeneOntologyBiologicalProcess	sensory perception of smell	MKKS OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 DMXL2 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	1.12e-66	465	302	83	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	1.43e-62	485	302	81	GO:0050907
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	MKKS OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 DMXL2 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	6.89e-62	547	302	84	GO:0007606
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	8.58e-60	524	302	81	GO:0009593
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	MYC MKKS OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 PDZD7 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	1.32e-59	582	302	84	GO:0050906
GeneOntologyBiologicalProcess	detection of stimulus	MYC MKKS OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 PDZD7 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 NLRC4 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	5.13e-54	722	302	86	GO:0051606
GeneOntologyBiologicalProcess	sensory perception	MYC MKKS OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 PDZD7 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 DMXL2 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 TECTA OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 RPGR OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	6.10e-42	1072	302	88	GO:0007600
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR1M1 RASGRP4 OR5T1 PDE2A OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 ADCY9 OR8B3 ITPR1 OR10D4P OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 SLIT2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P ADGRD1 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4 OR2W6P	2.10e-35	1395	302	91	GO:0007186
GeneOntologyBiologicalProcess	regulation of receptor recycling	EPS15 ARAP1 PCSK9 GRIA3 LDLR	8.09e-05	31	302	5	GO:0001919
GeneOntologyBiologicalProcess	receptor recycling	EPS15 ARAP1 PCSK9 GRIA3 ALS2 LDLR	1.49e-04	55	302	6	GO:0001881
Domain	Olfact_rcpt	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	1.82e-60	393	291	75	IPR000725
Domain	G_PROTEIN_RECEP_F1_1	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	1.65e-46	685	291	79	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	3.19e-46	691	291	79	PS50262
Domain	GPCR_Rhodpsn	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	3.56e-46	692	291	79	IPR000276
Domain	GPCR_Rhodpsn_7TM	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 VN1R2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	3.74e-45	670	291	77	IPR017452
Domain	7tm_1	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2T1 GPR52 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 GPR142 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OXER1 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR11H12 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	8.05e-45	677	291	77	PF00001
Domain	Aquaporin_11/12	AQP12A AQP11 AQP12B	3.74e-06	3	291	3	IPR016697
Domain	RCC1	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.14e-05	20	291	5	PF00415
Domain	RCC1_1	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.47e-05	21	291	5	PS00625
Domain	RCC1_2	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.47e-05	21	291	5	PS00626
Domain	RCC1_3	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.47e-05	21	291	5	PS50012
Domain	Tyr_kinase_non-rcpt_Jak/Tyk2	TYK2 JAK1 JAK3	1.48e-05	4	291	3	IPR016251
Domain	-	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.88e-05	22	291	5	2.130.10.30
Domain	Reg_chr_condens	RCBTB2 HERC2 ALS2 NEK8 RPGR	1.88e-05	22	291	5	IPR000408
Domain	WD40/YVTN_repeat-like_dom	DCAF8 WDR18 SEMA3G LYST DMXL1 PWP2 DCAF4L1 TRAF7 SEMA4D SEMA3C DMXL2 DCAF8L2 NBEA SEMA4G WDR45 LLGL1 WDFY3	2.17e-05	335	291	17	IPR015943
Domain	RCC1/BLIP-II	RCBTB2 HERC2 ALS2 NEK8 RPGR	2.37e-05	23	291	5	IPR009091
Domain	WD40_repeat_dom	KNTC1 DCAF8 WDR18 LYST DMXL1 PWP2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 UBR4 NBEA WDR45 LLGL1 WDFY3	6.99e-05	297	291	15	IPR017986
Domain	PH_BEACH	LYST NBEA WDFY3	7.23e-05	6	291	3	PF14844
Domain	-	DCAF8 WDR18 SEMA3G LYST DMXL1 DCAF4L1 TRAF7 SEMA4D SEMA3C DMXL2 DCAF8L2 NBEA SEMA4G WDR45 LLGL1 WDFY3	7.26e-05	333	291	16	2.130.10.10
Domain	WD40_repeat	DCAF8 WDR18 LYST DMXL1 PWP2 HERC2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	9.95e-05	272	291	14	IPR001680
Domain	-	SLIT2 ADGRD1 LAMA5 NBEA CRP PAPPA EGFLAM WDFY3	1.19e-04	95	291	8	2.60.120.200
Domain	WD_REPEATS_2	DCAF8 WDR18 LYST DMXL1 PWP2 HERC2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	1.30e-04	279	291	14	PS50082
Domain	WD_REPEATS_REGION	DCAF8 WDR18 LYST DMXL1 PWP2 HERC2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	1.30e-04	279	291	14	PS50294
Domain	PH-BEACH_dom	LYST NBEA WDFY3	1.98e-04	8	291	3	IPR023362
Domain	-	LYST NBEA WDFY3	1.98e-04	8	291	3	2.30.29.40
Domain	PH_BEACH	LYST NBEA WDFY3	1.98e-04	8	291	3	PS51783
Domain	ig	FCRL2 PDGFRA OBSCN SEMA3G MFAP3 FCRL3 KIR2DL4 UNC5D SEMA4D SDK2 FCRL5	2.01e-04	190	291	11	PF00047
Domain	Immunoglobulin	FCRL2 PDGFRA OBSCN SEMA3G MFAP3 FCRL3 KIR2DL4 UNC5D SEMA4D SDK2 FCRL5	2.01e-04	190	291	11	IPR013151
Domain	WD40	DCAF8 WDR18 LYST DMXL1 PWP2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	2.25e-04	259	291	13	PF00400
Domain	Semaphorin	SEMA3G SEMA4D SEMA3C SEMA4G	2.30e-04	20	291	4	IPR027231
Domain	Aquaporin_12	AQP12A AQP12B	2.42e-04	2	291	2	IPR023265
Domain	Rav1p_C	DMXL1 DMXL2	2.42e-04	2	291	2	IPR022033
Domain	NLGN4	NLGN4X NLGN4Y	2.42e-04	2	291	2	IPR030025
Domain	MINDY_domain	MINDY2 MINDY1	2.42e-04	2	291	2	IPR033979
Domain	DUF544	MINDY2 MINDY1	2.42e-04	2	291	2	PF04424
Domain	MINDY	MINDY2 MINDY1	2.42e-04	2	291	2	IPR007518
Domain	Rav1p_C	DMXL1 DMXL2	2.42e-04	2	291	2	PF12234
Domain	BEACH	LYST NBEA WDFY3	2.93e-04	9	291	3	PS50197
Domain	Beach	LYST NBEA WDFY3	2.93e-04	9	291	3	PF02138
Domain	-	LYST NBEA WDFY3	2.93e-04	9	291	3	1.10.1540.10
Domain	Beach	LYST NBEA WDFY3	2.93e-04	9	291	3	SM01026
Domain	BEACH_dom	LYST NBEA WDFY3	2.93e-04	9	291	3	IPR000409
Domain	WD40	DCAF8 WDR18 LYST DMXL1 PWP2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	3.13e-04	268	291	13	SM00320
Domain	IGc2	FCRL2 PDGFRA OBSCN IGSF10 MFAP3 FCRL3 HMCN2 UNC5D SEMA4D SDK2 LRIG3 FCRL5	3.33e-04	235	291	12	SM00408
Domain	Ig_sub2	FCRL2 PDGFRA OBSCN IGSF10 MFAP3 FCRL3 HMCN2 UNC5D SEMA4D SDK2 LRIG3 FCRL5	3.33e-04	235	291	12	IPR003598
Domain	IG	FCRL2 PDGFRA OBSCN SEMA3G IGSF10 MFAP3 FCRL3 HMCN2 KIR2DL4 UNC5D SEMA4D SEMA3C SDK2 TAPBPL SEMA4G LRIG3 FCRL5	3.48e-04	421	291	17	SM00409
Domain	Ig_sub	FCRL2 PDGFRA OBSCN SEMA3G IGSF10 MFAP3 FCRL3 HMCN2 KIR2DL4 UNC5D SEMA4D SEMA3C SDK2 TAPBPL SEMA4G LRIG3 FCRL5	3.48e-04	421	291	17	IPR003599
Domain	WD_REPEATS_1	DCAF8 WDR18 LYST DMXL1 PWP2 HERC2 DCAF4L1 TRAF7 DMXL2 NBEA WDR45 LLGL1 WDFY3	4.43e-04	278	291	13	PS00678
Domain	PSI	SEMA3G ITGB7 SEMA4D SEMA3C SEMA4G	5.86e-04	44	291	5	IPR016201
Domain	PSI	SEMA3G ITGB7 SEMA4D SEMA3C SEMA4G	7.21e-04	46	291	5	SM00423
Domain	IG_LIKE	FCRL2 PDGFRA OBSCN SEMA3G IGSF10 MFAP3 FCRL3 HMCN2 KIR2DL4 UNC5D SEMA4D SEMA3C SDK2 TAPBPL LEPR SEMA4G LRIG3 FCRL5	7.34e-04	491	291	18	PS50835
Domain	Ig_I-set	FCRL2 PDGFRA OBSCN IGSF10 MFAP3 HMCN2 UNC5D SEMA3C SDK2 LRIG3	8.19e-04	190	291	10	IPR013098
Domain	I-set	FCRL2 PDGFRA OBSCN IGSF10 MFAP3 HMCN2 UNC5D SEMA3C SDK2 LRIG3	8.19e-04	190	291	10	PF07679
Domain	Ig-like_dom	FCRL2 PDGFRA OBSCN SEMA3G IGSF10 MFAP3 FCRL3 HMCN2 KIR2DL4 UNC5D SEMA4D SEMA3C SDK2 TAPBPL LEPR SEMA4G LRIG3 FCRL5	9.66e-04	503	291	18	IPR007110
Domain	MIP	AQP12A AQP11 AQP12B	1.20e-03	14	291	3	PF00230
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH10 DNAH1	1.20e-03	14	291	3	IPR011704
Domain	MIP	AQP12A AQP11 AQP12B	1.20e-03	14	291	3	PS00221
Domain	AAA_5	MDN1 DNAH10 DNAH1	1.20e-03	14	291	3	PF07728
Domain	Semap_dom	SEMA3G SEMA4D SEMA3C SEMA4G	1.30e-03	31	291	4	IPR001627
Domain	SEMA	SEMA3G SEMA4D SEMA3C SEMA4G	1.30e-03	31	291	4	PS51004
Domain	Sema	SEMA3G SEMA4D SEMA3C SEMA4G	1.30e-03	31	291	4	SM00630
Domain	Sema	SEMA3G SEMA4D SEMA3C SEMA4G	1.30e-03	31	291	4	PF01403
Domain	-	AQP12A AQP11 AQP12B	1.48e-03	15	291	3	1.20.1080.10
Domain	Aquaporin-like	AQP12A AQP11 AQP12B	1.48e-03	15	291	3	IPR023271
Domain	MIP	AQP12A AQP11 AQP12B	1.48e-03	15	291	3	IPR000425
Domain	UPA	UNC5D UNC5CL	2.35e-03	5	291	2	PF17217
Domain	Nlgn	NLGN4X NLGN4Y	2.35e-03	5	291	2	IPR000460
Domain	UPA	UNC5D UNC5CL	2.35e-03	5	291	2	IPR033772
Domain	DUF4704	NBEA WDFY3	2.35e-03	5	291	2	IPR031570
Domain	DUF4704	NBEA WDFY3	2.35e-03	5	291	2	PF15787
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	9.44e-58	417	233	75	M4072
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR1M1 OR5T1 OR5M10 OR10A7 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 OR5M3 OR5M8 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR51B2 OR2AE1 OR1L4	1.12e-53	389	233	70	M14091
Pathway	REACTOME_SENSORY_PERCEPTION	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR1N2 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR51B5 OR5J2 OR13D1 OR5AC2 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR5K2 OR2Z1 OR5K1 OR7A10 OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5A2 APOB OR5M3 OR5M8 OR5AR1 OR1D4 LDLR OR4K14 OR10A3 OR3A1 OR6V1 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR2AE1 OR1L4	4.05e-46	636	233	77	M41834
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR2T1 OR2T4 OR8B3 OR1N2 OR2W3 OR2B11 OR1A1 OR1D5 OR1E1 OR1E2 OR5K2 OR5K1 OR5P3 OR10A3 OR10A6 OR8B2	2.08e-14	70	233	16	MM14984
Pathway	WP_GPCRS_ODORANT	OR1M1 OR5T1 OR7E24 OR7A5 OR2B6 OR8B3 OR5J2 GPR142 OR1E1 OR1E2 OR7A10 OR7A2P ADGRD1 OR5P2 OR5P3 OR5B21 OR5T2 OR5AR1 OR8B2	1.24e-11	157	233	19	MM15872
Pathway	REACTOME_SENSORY_PERCEPTION	OR2T1 OR2T4 OR8B3 OR1N2 OR2W3 OR2B11 OR1A1 OR1D5 OR1E1 OR1E2 OR5K2 OR5K1 OR5P3 APOB OR10A3 OR10A6 OR8B2	1.67e-08	190	233	17	MM15687
Pathway	WP_GPCRS_OTHER	OR1M1 OR7E24 OR7A5 OR2T1 OR2B6 OR1A1 OR1D5 OR1E1 OR1E2 OR7A10 OR7A2P OR3A1	5.75e-08	96	233	12	MM15939
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	OR7C2 OR7A5 OR2T1 GPR52 OR2H1 OR2B6 OR1A1 OR1D5 OR1E1 OR1E2 OR7A10 OR2H2 OR2B2 OR5V1 OR1D4 OR3A1	6.78e-06	260	233	16	M39397
Pathway	WP_GPCRS_OTHER	OR7E24 OR2H1 OR2B6 OR2M4 OR5AC2 OR1E1 ADGRD1 OR3A1	1.50e-04	93	233	8	M39629
Pathway	BIOCARTA_STAT3_PATHWAY	TYK2 JAK1 JAK3	2.35e-04	8	233	3	M22063
Pathway	BIOCARTA_STAT3_PATHWAY	TYK2 JAK1 JAK3	2.35e-04	8	233	3	MM1576
Pathway	BIOCARTA_IL22BP_PATHWAY	TYK2 JAK1 JAK3	3.48e-04	9	233	3	M8066
Pathway	BIOCARTA_IL22BP_PATHWAY	TYK2 JAK1 JAK3	3.48e-04	9	233	3	MM1419
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR1M1 OR5T1 OR5M10 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2V1 OR2T1 OR2T12 OR2H1 OR2T4 OR2B6 OR8B3 OR10D4P OR1N2 OR2T8 OR2W3 OR2B11 OR2K2 OR5J2 OR13D1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5M3 OR5M8 OR5AR1 OR10A3 OR3A1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR1L4 OR2W6P	1.99e-65	340	312	64	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR1M1 OR5T1 OR5M10 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2V1 OR2T1 OR2T12 OR2H1 OR2T4 OR2B6 OR8B3 OR10D4P OR1N2 OR2T8 OR2W3 OR2B11 OR2K2 OR5J2 OR13D1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5M3 OR5M8 OR5AR1 OR10A3 OR3A1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR1L4 OR2W6P	1.99e-65	340	312	64	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR1M1 OR5T1 OR5M10 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2V1 OR2T1 OR2T12 OR2H1 OR2T4 OR2B6 OR8B3 OR10D4P OR1N2 OR2T8 OR2W3 OR2B11 OR2K2 OR5J2 OR13D1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5M3 OR5M8 OR5AR1 OR10A3 OR3A1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR1L4 OR2W6P	3.62e-65	343	312	64	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR1M1 OR5T1 OR5M10 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2V1 OR2T1 OR2T12 OR2H1 OR2T4 OR2B6 OR8B3 OR10D4P OR1N2 OR2T8 OR2W3 OR2B11 OR2K2 OR5J2 OR13D1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5M3 OR5M8 OR5AR1 OR10A3 OR3A1 OR5H8 OR10A6 OR2A25 OR2V2 OR51V1 OR8B2 OR51B2 OR1L4 OR2W6P	6.55e-65	346	312	64	14611657
Pubmed	The human olfactory receptor gene family.	OR1M1 OR5T1 OR5M10 OR10A7 OR5AC1 OR7E24 OR5M1 OR2T33 OR5AK2 OR7C2 OR7A5 OR2C3 OR2T1 OR2T12 OR2T10 OR2H1 OR3A4P OR2T4 OR2B6 OR1L3 OR1L1 OR8B3 OR10D4P OR1N2 OR2M4 OR2W3 OR2K2 OR51B5 OR5J2 OR13D1 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR5K2 OR2Z1 OR5K1 OR7A10 OR7A2P OR9A2 OR2H2 OR5P2 OR5P3 OR5B3 OR2B2 OR2T27 OR5V1 OR11G2 OR5G3 OR1S1 OR1S2 OR5T2 OR5A2 OR5M3 OR5M8 OR5AR1 OR1D4 OR4K14 OR10A3 OR3A1 OR6V1 OR5H8 OR10A6 OR2V2 OR51V1 OR8B2 OR1L4 OR2W6P	7.64e-60	541	312	70	14983052
Pubmed	DEFOG: a practical scheme for deciphering families of genes.	OR1M1 OR10A7 OR7E24 OR5M1 OR7C2 OR7A5 OR2C3 OR2T1 OR3A4P OR1N2 OR2T8 OR2M4 OR2W3 OR11H1 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR2Z1 OR7A10 OR7A2P OR2H2 OR5P3 OR11G2 OR1S2 OR5A2 OR5M3 OR5M8 OR1D4 OR4K14 OR10A3 OR2V2 OR8B2 OR51B2 OR1L4	5.52e-36	219	312	37	12213199
Pubmed	Odorant and vomeronasal receptor genes in two mouse genome assemblies.	OR5AC1 OR7C2 OR2T4 OR10D4P OR2W3 OR1A1 OR1E1 OR1E2 OR2Z1 OR7A10 OR5P2 OR2B2 OR11G2	1.22e-13	74	312	13	15081110
Pubmed	Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species.	OR1M1 OR7E24 OR7A5 OR2T1 OR2M4 OR1E1 OR1E2 OR7A10 OR7A2P	3.90e-13	24	312	9	9119360
Pubmed	Expert curation of the human and mouse olfactory receptor gene repertoires identifies conserved coding regions split across two exons.	OR7E24 OR2V1 OR2T12 OR2T8 OR2M4 OR1A1 OR5K1 OR7A10 OR2T27 OR2V2	8.96e-12	46	312	10	32126975
Pubmed	The olfactory receptor gene repertoire in primates and mouse: evidence for reduction of the functional fraction in primates.	OR7C2 OR7A5 OR5AC2 OR1A1 OR1E1 OR1E2 OR7A10 OR7A2P	1.67e-11	23	312	8	10706615
Pubmed	Sequence, structure, and evolution of a complete human olfactory receptor gene cluster.	OR3A4P OR1A1 OR1D5 OR1E1 OR1E2 OR1D4 OR3A1	4.67e-11	16	312	7	10673334
Pubmed	Expression of members of the putative olfactory receptor gene family in mammalian germ cells.	OR7A5 OR2M4 OR2K2 OR5J2 OR1E1 OR5K1 OR10A3	1.83e-09	25	312	7	1370859
Pubmed	Mouse-human orthology relationships in an olfactory receptor gene cluster.	OR1A1 OR1D5 OR1E1 OR1E2 OR3A1	3.08e-09	8	312	5	11170746
Pubmed	Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures.	OR5AC1 OR7A5 OR7A10 OR7A2P OR11G2 OR5AR1 OR5H8	3.33e-09	27	312	7	32061665
Pubmed	Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire.	OR3A4P OR1E1 OR1E2 OR1D4 OR3A1	2.49e-08	11	312	5	8004088
Pubmed	The chromosomal distribution of mouse odorant receptor genes.	OR2B6 OR8B3 OR1E1 OR1E2 OR7A10 OR5P3 OR5T2 OR8B2	2.79e-08	54	312	8	8570653
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-21 ERVK-19	3.15e-08	5	312	4	12629516
Pubmed	Evolution of odorant receptors expressed in mammalian testes.	OR7A5 OR1E1 OR1E2 OR7A10 OR7A2P	6.83e-08	13	312	5	11014824
Pubmed	The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.	PCSK9 APOB LDLR	7.15e-07	3	312	3	19319977
Pubmed	Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	20538126
Pubmed	The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	33418990
Pubmed	Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	17539906
Pubmed	A systematic review of LDLR, PCSK9, and APOB variants in Asia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	32629184
Pubmed	Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.	PCSK9 APOB LDLR	7.15e-07	3	312	3	34756585
Pubmed	Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.	PCSK9 APOB LDLR	7.15e-07	3	312	3	25839937
Pubmed	Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.	APOB LDLR CRP	7.15e-07	3	312	3	17702862
Pubmed	Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations.	PCSK9 APOB LDLR	7.15e-07	3	312	3	20145306
Pubmed	Genomics of familial hypercholesterolaemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	30844855
Pubmed	Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate.	PCSK9 APOB LDLR	7.15e-07	3	312	3	16159606
Pubmed	PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction.	PCSK9 LDLR LEPR	7.15e-07	3	312	3	29180444
Pubmed	Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.	PCSK9 APOB LDLR	7.15e-07	3	312	3	29261184
Pubmed	Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project.	PCSK9 APOB LDLR	7.15e-07	3	312	3	20236128
Pubmed	Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	23593297
Pubmed	Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.	PCSK9 APOB LDLR	7.15e-07	3	312	3	17142622
Pubmed	The genetic spectrum of familial hypercholesterolemia in the central south region of China.	PCSK9 APOB LDLR	7.15e-07	3	312	3	28235710
Pubmed	Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	37853441
Pubmed	Editorial: designing targeted sequencing panels for dyslipidemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	30664017
Pubmed	Genetic heterogeneity of autosomal dominant hypercholesterolemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	18028451
Pubmed	Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.	PCSK9 APOB LDLR	7.15e-07	3	312	3	32770674
Pubmed	Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation.	PCSK9 APOB LDLR	7.15e-07	3	312	3	30400955
Pubmed	Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.	ANGPTL3 PCSK9 APOB	7.15e-07	3	312	3	22095935
Pubmed	Mutation screening in patients for familial hypercholesterolaemia (ADH).	PCSK9 APOB LDLR	7.15e-07	3	312	3	19843101
Pubmed	Translating genetic association of lipid levels for biological and clinical application.	PCSK9 APOB LDLR	7.15e-07	3	312	3	33604704
Pubmed	Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.	PCSK9 APOB LDLR	7.15e-07	3	312	3	23669246
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP PDE2A LZTR1 OBSCN RAP1GAP2 TMCO6 ZFPM1 LYST ADCY9 TYK2 JAK3 MDN1 POLL HERC2 TOP3B TRAPPC9 ARAP1 TRAF7 UBR4 LAMA5 LDLR NBPF1 TLNRD1 MROH1 NEK8 TTLL4 WDFY3 ATP2A3	9.65e-07	1105	312	28	35748872
Pubmed	Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.	ANGPTL3 PCSK9 APOB LDLR LEPR CRP ACSM2B	2.16e-06	66	312	7	20679960
Pubmed	Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor.	PCSK9 APOB LDLR	2.84e-06	4	312	3	22580899
Pubmed	Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.	PCSK9 APOB LDLR	2.84e-06	4	312	3	32044282
Pubmed	Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians.	PCSK9 APOB LDLR	2.84e-06	4	312	3	38874786
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-24	2.84e-06	4	312	3	10469592
Pubmed	Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.	PCSK9 APOB LDLR	2.84e-06	4	312	3	26802983
Pubmed	Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.	PCSK9 APOB LDLR	2.84e-06	4	312	3	30971288
Pubmed	Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.	TYK2 JAK1 JAK3	2.84e-06	4	312	3	24843152
Pubmed	Identification of ligands for olfactory receptors by functional expression of a receptor library.	OR2V1 OR2T1 OR1A1 OR7A10	2.97e-06	12	312	4	9875846
Pubmed	Distribution of olfactory receptor genes in the human genome.	OR7C2 OR2T1 OR2B6 OR1E1 OR1E2	4.67e-06	28	312	5	9500546
Pubmed	Information coding in the olfactory system: evidence for a stereotyped and highly organized epitope map in the olfactory bulb.	OR2B6 OR1E1 OR1E2 OR7A10	5.92e-06	14	312	4	7528109
Pubmed	Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.	FCRL2 FCRL3 FCRL5	7.06e-06	5	312	3	18704934
Pubmed	IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells.	FCRL2 FCRL3 FCRL5	7.06e-06	5	312	3	11929751
Pubmed	The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity.	TYK2 JAK1 JAK3	7.06e-06	5	312	3	10531356
Pubmed	Identification of a family of Fc receptor homologs with preferential B cell expression.	FCRL2 FCRL3 FCRL5	7.06e-06	5	312	3	11493702
Pubmed	Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.	FCRL2 FCRL3 FCRL5	7.06e-06	5	312	3	16849395
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	SEMA3G UNC5D SEMA4D SEMA3C SDK2 SEMA4G	7.15e-06	52	312	6	26633812
Pubmed	Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.	PCSK9 APOB LDLR CRP	1.06e-05	16	312	4	20691829
Pubmed	Chromosomal location-dependent nonstochastic onset of odor receptor expression.	OR7A5 OR7A10 OR7A2P OR5AR1	1.38e-05	17	312	4	20668191
Pubmed	Olfactory receptors and signalling elements in the Grueneberg ganglion.	OR1E1 OR1E2 OR7A10 OR5T2	1.38e-05	17	312	4	16805845
Pubmed	Visualizing an olfactory sensory map.	OR7A5 OR7A10 OR7A2P	1.40e-05	6	312	3	8929536
Pubmed	The molecular regulation of Janus kinase (JAK) activation.	TYK2 JAK1 JAK3	1.40e-05	6	312	3	25057888
Pubmed	A probabilistic classifier for olfactory receptor pseudogenes.	OR3A4P OR1S1 OR5AR1 OR10A6 OR51B2	1.46e-05	35	312	5	16939646
Pubmed	Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.	ANGPTL3 PCSK9 APOB LDLR	2.21e-05	19	312	4	19148283
Pubmed	Personal receptor repertoires: olfaction as a model.	OR5G3 OR1S1 OR5AR1 OR10A6 OR51B2	2.22e-05	38	312	5	22908908
Pubmed	Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.	PCSK9 APOB LDLR	2.44e-05	7	312	3	28958330
Pubmed	The molecular basis of JAK/STAT inhibition by SOCS1.	TYK2 JAK1 JAK3	2.44e-05	7	312	3	29674694
Pubmed	A single MIU motif of MINDY-1 recognizes K48-linked polyubiquitin chains.	EPS15 MINDY2 MINDY1	2.44e-05	7	312	3	28082312
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC LZTR1 DCAF8 ADCY9 TYK2 JAK1 HOXA9 SLIT2 NAA35 HMCN2 ABHD8 TADA2A ZDHHC13 UNC5D TRAF7 LDLR LRIG3 RAB11FIP5 ANKRD17 TTC39A SLFN11 WDFY3 CSMD1 KIF18B CDC27	2.99e-05	1116	312	25	31753913
Pubmed	STAM2, a new member of the STAM family, binding to the Janus kinases.	TYK2 JAK1 JAK3	3.87e-05	8	312	3	10899310
Pubmed	SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.	PCSK9 APOB LDLR	3.87e-05	8	312	3	23580231
Pubmed	Identification of potential regulatory motifs in odorant receptor genes by analysis of promoter sequences.	OR1E1 OR1E2 OR11G2	3.87e-05	8	312	3	16902085
Pubmed	Familial Hypercholesterolemia	PCSK9 APOB LDLR	3.87e-05	8	312	3	24404629
Pubmed	Identification of genetic variants associated with response to statin therapy.	PCSK9 APOB LDLR	5.77e-05	9	312	3	19667110
Pubmed	Polymorphisms associated with cholesterol and risk of cardiovascular events.	PCSK9 APOB LDLR	5.77e-05	9	312	3	18354102
Pubmed	A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.	PCSK9 APOB LDLR	5.77e-05	9	312	3	19773416
Pubmed	Sensitivity-dependent hierarchical receptor codes for odors.	OR1E1 OR1E2 OR5B21	5.77e-05	9	312	3	12588732
Pubmed	Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.	PDGFRA TYK2 JAK1	5.77e-05	9	312	3	9484840
Pubmed	Genetic variants influencing circulating lipid levels and risk of coronary artery disease.	ANGPTL3 PCSK9 MYO1H APOB LDLR	7.76e-05	49	312	5	20864672
Pubmed	C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor.	LEPR CRP	8.02e-05	2	312	2	29910808
Pubmed	Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.	PCSK9 APOB	8.02e-05	2	312	2	21502677
Pubmed	[A genetic and clinical study in a family with familial hypercholesterolemia].	APOB LDLR	8.02e-05	2	312	2	21418831
Pubmed	PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.	PCSK9 LDLR	8.02e-05	2	312	2	24144304
Pubmed	Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance TRAFFn, T1ρ and T2 relaxation times.	APOB LDLR	8.02e-05	2	312	2	36709358
Pubmed	Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.	JAK1 JAK3	8.02e-05	2	312	2	18559588
Pubmed	Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.	PCSK9 LDLR	8.02e-05	2	312	2	19224862
Pubmed	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	PCSK9 LDLR	8.02e-05	2	312	2	23690465
Pubmed	Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.	PCSK9 LDLR	8.02e-05	2	312	2	27470509
Pubmed	Binding to the low-density lipoprotein receptor accelerates futile catalytic cycling in PCSK9 and raises the equilibrium level of intramolecular acylenzyme.	PCSK9 LDLR	8.02e-05	2	312	2	19222187
Pubmed	New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice.	PCSK9 LDLR	8.02e-05	2	312	2	33737240
Pubmed	PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease.	PCSK9 CRP	8.02e-05	2	312	2	32577988
Pubmed	PCSK9 inhibitor therapy in homozygous familial defective apolipoprotein B-100 due to APOB R3500Q: A case report.	PCSK9 APOB	8.02e-05	2	312	2	28988723
Pubmed	Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor.	PCSK9 LDLR	8.02e-05	2	312	2	24486405
Pubmed	Destabilization of β Cell FIT2 by saturated fatty acids alter lipid droplet numbers and contribute to ER stress and diabetes.	LEPR FITM2	8.02e-05	2	312	2	35254894
Pubmed	Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity.	APOB LDLR	8.02e-05	2	312	2	36950286
Cytoband	11q12.1	OR5T1 OR5M10 OR5M1 OR5AK2 OR5B3 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR5AR1	2.49e-14	161	311	16	11q12.1
Cytoband	1q44	OR2T33 OR2C3 OR2T1 OR2T12 OR2T10 OR2T4 OR2T8 OR2M4 OR2W3 OR2B11 OR2T27 KIF26B	1.47e-11	110	311	12	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr11q12	OR5T1 OR5M10 OR5M1 OR5AK2 OR5J2 MS4A13 OR5B3 OR5G3 OR1S1 OR1S2 OR9Q2 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR5AR1	3.59e-11	345	311	18	chr11q12
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	OR2T33 OR2C3 OR2T1 OR2T12 OR2T10 OR2T4 OR2T8 OR2M4 OR2W3 OR2B11 OR2T27 KIF26B	8.90e-11	128	311	12	chr1q44
Cytoband	9q33.2	OR1L3 OR1L1 OR1N2 OR1L6 OR1K1 PAPPA OR1L4	7.82e-09	39	311	7	9q33.2
Cytoband	17p13.3	RAP1GAP2 OR3A4P OR1A1 OR1D5 OR1E1 OR1E2 OR1D4 OR3A1 ATP2A3	9.57e-09	88	311	9	17p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q33	DAB2IP OR1L3 OR1L1 OR1N2 OR1L6 OR1K1 PAPPA OR1L4	5.02e-06	138	311	8	chr9q33
Cytoband	Ensembl 112 genes in cytogenetic band chr3q11	OR5AC1 OR5AC2 OR5K2 OR5K1 OR5H8	3.33e-05	54	311	5	chr3q11
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	OR1M1 OR7E24 OR7C2 OR7A5 CATSPERD WDR18 TYK2 JAK3 ABHD8 OR2Z1 OR7A10 OR7A2P ZNF433 DCAF15 LDLR	4.07e-04	797	311	15	chr19p13
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	RAP1GAP2 OR3A4P OR1A1 OR1D5 OR1E1 OR1E2 OR1D4 OR3A1 ATP2A3	6.48e-04	346	311	9	chr17p13
Cytoband	3q11.2	OR5AC1 OR5K2 OR5K1	7.13e-04	26	311	3	3q11.2
Cytoband	15q13	HERC2 TLNRD1	1.60e-03	9	311	2	15q13
GeneFamily	Olfactory receptors, family 5	OR5T1 OR5M10 OR5AC1 OR5M1 OR5AK2 OR5J2 OR5AC2 OR5K2 OR5K1 OR5P2 OR5P3 OR5B3 OR5V1 OR5G3 OR5B21 OR5T2 OR5AK3P OR5A2 OR5M3 OR5M8 OR5AR1 OR5H8	2.50e-19	112	253	22	152
GeneFamily	Olfactory receptors, family 2	OR2T33 OR2C3 OR2V1 OR2T1 OR2T12 OR2T10 OR2H1 OR2T4 OR2B6 OR2T8 OR2M4 OR2W3 OR2B11 OR2K2 OR2Z1 OR2H2 OR2B2 OR2T27 OR2A25 OR2V2 OR2AE1 OR2W6P	3.07e-19	113	253	22	149
GeneFamily	Olfactory receptors, family 1	OR1M1 OR1L3 OR1L1 OR1N2 OR1A1 OR1D5 OR1L6 OR1E1 OR1E2 OR1K1 OR1S1 OR1S2 OR1D4 OR1L4	1.29e-16	40	253	14	147
GeneFamily	WD repeat domain containing	DCAF8 WDR18 LYST DMXL1 PWP2 DCAF4L1 TRAF7 DMXL2 DCAF8L2 NBEA WDR45 LLGL1 WDFY3	8.64e-05	262	253	13	362
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA3G SEMA4D SEMA3C SEMA4G	1.52e-04	20	253	4	736
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEA WDFY3	2.14e-04	9	253	3	1230
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PDGFRA OBSCN IGSF10 MFAP3 HMCN2 UNC5D SEMA3C SDK2 LRIG3	4.50e-04	161	253	9	593
GeneFamily	Aquaporins	AQP12A AQP11 AQP12B	8.79e-04	14	253	3	305
GeneFamily	Immunoglobulin like domain containing	FCRL2 SEMA3G FCRL3 HMCN2 SEMA4D SDK2 LEPR SEMA4G FCRL5	1.63e-03	193	253	9	594
GeneFamily	Olfactory receptors, family 3	OR3A4P OR3A1	2.82e-03	6	253	2	150
GeneFamily	SUMO specific peptidases\|5FMC ribosome biogenesis complex	WDR18 NOL9	2.82e-03	6	253	2	1301
GeneFamily	Olfactory receptors, family 11	OR11H1 OR11G2 OR11H12	3.90e-03	23	253	3	159
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CSMD3 SSPOP PIK3C2G UNC5D DNAH10 KIF26B SALL4 APOB DNAH1 CSMD1	6.01e-08	184	304	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CSMD3 SSPOP PIK3C2G UNC5D DNAH10 KIF26B SALL4 APOB DNAH1 CSMD1	6.01e-08	184	304	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CSMD3 SSPOP PIK3C2G UNC5D DNAH10 KIF26B SALL4 APOB DNAH1 CSMD1	6.01e-08	184	304	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	356C-Lymphocytic-ILC-ILC-2\|ILC / Donor, Lineage, Cell class and subclass (all cells)	TMCO6 SPTBN5 MMP19 TRAPPC9 PMS2 CRACR2A XPO4 ZNF514 LLGL1 ACSM2B	3.12e-07	172	304	10	4977e1f4deae781750e27a8054deccd336cfb74a
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA OBSCN CSMD3 TSSK3 MMP19 FKBP10 GRIA3 ABCA6 PAPPA	3.22e-06	174	304	9	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 ZNF184 AGL ELAPOR1 PXYLP1 TOP3B NLRC3 PDPR LCORL	5.07e-06	184	304	9	d48807f9da48bdd015a54c606d2e2a311f181396
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 ZNF184 AGL ELAPOR1 PXYLP1 TOP3B NLRC3 PDPR LCORL	5.30e-06	185	304	9	7925519b855f76444a0b57382ce35d89457b0b14
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 AEBP1 MMP19 ADGRD1 CP ABCA6 EGFLAM CSMD1	7.16e-06	192	304	9	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FCRL2 ITPR1 OR1N2 FCRL3 SLC23A2 DOCK8 SSPN FCRL5 ACSM2A	8.11e-06	195	304	9	3311a1bf4ed94820b45047d44fc14b14ac72e6fb
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	SSPOP AEBP1 UGT2B4 ZNF433 SALL4 TECTA TTLL4 EGFLAM DYNLT4	9.55e-06	199	304	9	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRA SLIT2 AEBP1 FKBP10 LEPR SSPN KLK4 ABCA6 PAPPA	9.55e-06	199	304	9	fb580e9321ddf97c73b2e356cd82523db74a38a2
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 AQP11 PAQR6 ITPR1 NLRC3 BATF ALS2 TTI1	9.55e-06	199	304	9	6e7f7214317f2af2ba8523df9896f54b7294d58a
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 AQP11 PAQR6 ITPR1 NLRC3 BATF ALS2 TTI1	9.55e-06	199	304	9	5f499595597c10857bba8272f62afe4d32d733ac
ToppCell	normal_Lung-Fibroblasts\|normal_Lung / Location, Cell class and cell subclass	MYC PDGFRA IGSF10 SLIT2 AEBP1 FKBP10 LEPR SSPN ABCA6	9.94e-06	200	304	9	803cf7f1382d07220249029cd220233232027689
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYC PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 LEPR ABCA6	9.94e-06	200	304	9	05486d86868f6a93429226063cca270f00dd8714
ToppCell	proximal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYC PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 LEPR ABCA6	9.94e-06	200	304	9	869d45b71efd395d050873db5fee2ed0443d5e6f
ToppCell	Biopsy_Other_PF-Mesenchymal-Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PDGFRA IGSF10 SLIT2 HMCN2 AEBP1 FKBP10 LEPR SSPN ABCA6	9.94e-06	200	304	9	9996b6887cf2b1936e10a1aa396f09fd8da5f4c4
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA IGSF10 SLIT2 AEBP1 ADGRD1 FKBP10 SEMA3C CP SSPN	9.94e-06	200	304	9	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYC PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 LEPR ABCA6	9.94e-06	200	304	9	58c5870030192b337e7d883044948634fcd17d2c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA IGSF10 SLIT2 AEBP1 ADGRD1 FKBP10 SEMA3C CP ABCA6	9.94e-06	200	304	9	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	COVID-19_Mild-Neu_3\|World / 5 Neutrophil clusters in COVID-19 patients	OBSCN CSMD3 NLGN4X SDK2 APOB LRIG3 CSMD1	2.07e-05	122	304	7	2aa9cfadab70312882ae679e3788fc7ab996c0f3
ToppCell	10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory\|Liver / Manually curated celltypes from each tissue	FCRL2 FCRL3 NLGN4X SHOC1 IGKV2D-28 IGKV2-28 SSPN FCRL5	2.35e-05	171	304	8	eb47f4a09a630ed14a0898377039ed50ef7cc292
ToppCell	356C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TMCO6 SPTBN5 MMP19 TRAPPC9 XPO4 ZNF514 LLGL1 ACSM2B	2.35e-05	171	304	8	3d26ef58fe5231373d7df9ac79d225546918cf82
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AQP11 NECAB1 ADGRD1 GRIA3 IDH2 LDLR CD93 MFSD13A	2.66e-05	174	304	8	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA NLGN4X AEBP1 ADGRD1 NLGN4Y ST6GALNAC2 ABCA6 EGFLAM	2.66e-05	174	304	8	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA NLGN4X AEBP1 ADGRD1 NLGN4Y ST6GALNAC2 ABCA6 EGFLAM	2.66e-05	174	304	8	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	Control-B_cells-B_cells\|Control / group, cell type (main and fine annotations)	FCRL2 ITPR1 FCRL3 SDK2 DOCK8 SSPN FCRL5 ATP2A3	2.89e-05	176	304	8	d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA OBSCN NLGN4X AEBP1 FKBP10 SDK2 FRY PAPPA	3.26e-05	179	304	8	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZNF845 C1GALT1 URB2 ITGB7 KIR2DL4 ZDHHC13 CRACR2A	3.28e-05	131	304	7	cc5b5afab8622e98f673fa116a226d930c295327
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 CFAP54 NECAB1 UNC5D TNS3 SEMA4D DOCK8 WDFY3	3.67e-05	182	304	8	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CATSPERD PDZD7 PAQR6 IGSF10 HMCN2 ADGRD1 DNAH1	4.36e-05	137	304	7	a69976938d4e89315ec0be3a332b91ddf3799d65
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTTNBP2 PDGFRA OBSCN NLGN4X LAMA5 SALL4 ZNF532 PAPPA	4.61e-05	188	304	8	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 AEBP1 MMP19 ADGRD1 ABCA6 EGFLAM CSMD1	4.79e-05	189	304	8	544d95df910f1b276995624509a7e41b219baca0
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AEBP1 ADGRD1 FKBP10 SEMA3C NLGN4Y GRIA3 SSPN PAPPA	4.79e-05	189	304	8	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RASGRP4 CTTNBP2 OR2B11 TPSG1 MMP19 DMXL2 LDLR CD93	4.79e-05	189	304	8	2aebea7a6c2f83112d7c504b742f2c04b92e459a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADCY9 SLIT2 AEBP1 MMP19 SDK2 KIF26B ABCA6 PAPPA	4.79e-05	189	304	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 AEBP1 MMP19 ADGRD1 CP EGFLAM CSMD1	5.35e-05	192	304	8	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 ABCA6 PAPPA	5.35e-05	192	304	8	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 ABCA6 PAPPA	5.35e-05	192	304	8	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 AEBP1 MMP19 ADGRD1 CP EGFLAM CSMD1	5.35e-05	192	304	8	04d155897ed075c359933080e36a4ab2150b6e9f
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 SLIT2 AEBP1 MMP19 FKBP10 ABCA6 PAPPA	5.35e-05	192	304	8	ac1477433704573f95111eee6263b93668d2845e
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A ADAM18 C1GALT1 ELAPOR1 TPSG1 ARAP1 TTC39A ATP2A3	5.55e-05	193	304	8	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A C1GALT1 ITPR1 ELAPOR1 TPSG1 PCSK9 TTC39A ATP2A3	5.55e-05	193	304	8	4aee372ba2c0351b0221d0d468707d1ad21526d6
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A C1GALT1 ITPR1 ELAPOR1 TPSG1 PCSK9 TTC39A ATP2A3	5.55e-05	193	304	8	aaa5042388dc451bff384c6bb237348f08280a08
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA IGSF10 AEBP1 FKBP10 BATF LEPR PAPPA EGFLAM	5.97e-05	195	304	8	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PXYLP1 SLC29A4 TECTA NCAPH ST6GALNAC2 TMEM132E TTC39A	5.99e-05	144	304	7	b622b605f7ec6083ec06c8ea0fd171e07c52f3de
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRA SLIT2 AEBP1 LEPR SSPN KLK4 ABCA6 PAPPA	6.18e-05	196	304	8	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ELAPOR1 TPSG1 CRACR2A LDLR KLK4 TTC39A ATP2A3 ENTPD8	6.18e-05	196	304	8	847b3377f463bfded046eec63cc1b547f3dc33c1
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRA SLIT2 AEBP1 LEPR SSPN KLK4 ABCA6 PAPPA	6.18e-05	196	304	8	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAXDC2 ELAPOR1 TPSG1 CRACR2A FRY TTC39A ATP2A3 ENTPD8	6.18e-05	196	304	8	c2d17630f7bfc9e727de55e093c17fddac61b61f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRA SLIT2 AEBP1 LEPR SSPN KLK4 ABCA6 PAPPA	6.18e-05	196	304	8	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAXDC2 ELAPOR1 TPSG1 CRACR2A FRY TTC39A ATP2A3 ENTPD8	6.18e-05	196	304	8	54c30023d04e7265373647f56fc93885804938b0
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ELAPOR1 TPSG1 CRACR2A LDLR KLK4 TTC39A ATP2A3 ENTPD8	6.41e-05	197	304	8	d624f3a105b19f19a0dd253ce8de3ed13adc1f01
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	OR2T12 OR1N2 SLIT2 PIK3C2G SHOC1 SEMA3C APOB	6.53e-05	146	304	7	e887e9de895fd453faa703997ef372cc6410fc49
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA ADH5 IGSF10 SLIT2 MMP19 FKBP10 SDK2 ABCA6	6.88e-05	199	304	8	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA IGSF10 SLIT2 MMP19 FKBP10 SDK2 CP ABCA6	6.88e-05	199	304	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA IGSF10 SLIT2 ADGRD1 SDK2 LDLR ABCA6 PAPPA	6.88e-05	199	304	8	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA ADH5 IGSF10 SLIT2 MMP19 FKBP10 SDK2 ABCA6	6.88e-05	199	304	8	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	356C-Fibroblasts-Fibroblast-F\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRA SLIT2 AEBP1 FKBP10 SEMA3C LEPR SSPN ABCA6	6.88e-05	199	304	8	59fe5f3c6338e019a149ab135acf9cc5657298bf
ToppCell	356C-Fibroblasts-Fibroblast-F-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDGFRA SLIT2 AEBP1 FKBP10 SEMA3C LEPR SSPN ABCA6	6.88e-05	199	304	8	136f24597ddca5cf2175120975c94782a3232ec6
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 RAP1GAP2 OR1N2 TPSG1 SEMA4D BATF ATP2A3	7.12e-05	200	304	8	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDGFRA IGSF10 SLIT2 AEBP1 FKBP10 SSPN ABCA6 PAPPA	7.12e-05	200	304	8	8d2ceb2080c67b20f452eeca605aa27a58033c04
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	PDGFRA IGSF10 SLIT2 AEBP1 ADGRD1 CP LEPR ABCA6	7.12e-05	200	304	8	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 OR2C3 GPR142 TPSG1 HSPA1L BATF ATP2A3	7.12e-05	200	304	8	1c58860932ed47263a5a537a64f0343201463c21
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFRA OR2M4 SLIT2 AEBP1 LEPR KLK4 ABCA6 PAPPA	7.12e-05	200	304	8	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PDGFRA IGSF10 SLIT2 AEBP1 FKBP10 SSPN ABCA6 PAPPA	7.12e-05	200	304	8	c338a08c1605527ab9aaf62ea151a19e8469dc6d
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRA AEBP1 MMP19 ADGRD1 FKBP10 CP LEPR ABCA6	7.12e-05	200	304	8	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDGFRA IGSF10 SLIT2 AEBP1 FKBP10 SSPN ABCA6 PAPPA	7.12e-05	200	304	8	0b2614b8513693dd508c9003699049efd9abac52
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 OR2C3 GPR142 TPSG1 HSPA1L BATF ATP2A3	7.12e-05	200	304	8	c3511607692e05f44538a376253673dd18f77908
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RASGRP4 CTTNBP2 RAP1GAP2 OR1N2 TPSG1 SEMA4D BATF ATP2A3	7.12e-05	200	304	8	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	normal_Lung-Fibroblasts-COL14A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	MYC PDGFRA IGSF10 SLIT2 AEBP1 FKBP10 LEPR SSPN	7.12e-05	200	304	8	ee3d06865a6300e1279edf6664320b71647f5efb
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CFAP54 PDPR CD93 SSPN ABCA6 UHMK1 FITM2	7.74e-05	150	304	7	b6f1fc62d08199fed6156c7cd32f66d9926531b5
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OR2B11 MMP19 SEMA3C DMXL2 LDLR CD93 WDFY3	8.41e-05	152	304	7	072daae0deb6cb92f126e4566f1d264cda9ed157
ToppCell	356C-Lymphocytic-ILC-ILC-2\|356C / Donor, Lineage, Cell class and subclass (all cells)	TMCO6 SPTBN5 TRAPPC9 XPO4 ZNF514 LLGL1 ACSM2B	9.51e-05	155	304	7	0fd66c623cb433ceaa893bc21ba2e3b394faaf70
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	PDGFRA SLIT2 AEBP1 FKBP10 SDK2 SALL4 ABCA6	1.11e-04	159	304	7	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	KNTC1 PDE2A IGSF10 POLE2 IDH2 CCNF CDK3	1.30e-04	163	304	7	47300dec94dc66e965bf71fafff0a9fd24fae968
Disease	LDL cholesterol change measurement	PCSK9 APOB LDLR	2.76e-05	7	276	3	EFO_0007804
Disease	disease of cellular proliferation (implicated_via_orthology)	TYK2 JAK1 JAK3	2.76e-05	7	276	3	DOID:14566 (implicated_via_orthology)
Disease	Familial hypercholesterolemia	PCSK9 APOB LDLR	4.38e-05	8	276	3	cv:C0020445
Disease	hypobetalipoproteinemia (is_implicated_in)	PCSK9 APOB	8.72e-05	2	276	2	DOID:1390 (is_implicated_in)
Disease	X-21319 measurement	ACSM2A ACSM2B	8.72e-05	2	276	2	EFO_0800807
Disease	familial hypercholesterolemia (is_implicated_in)	PCSK9 APOB LDLR	9.25e-05	10	276	3	DOID:13810 (is_implicated_in)
Disease	level of Sterol ester (27:1/18:2) in blood serum	PCSK9 APOB LDLR ANKRD17	9.52e-05	26	276	4	OBA_2045194
Disease	T-cell acute lymphoblastic leukemia (is_implicated_in)	PDGFRA JAK1 JAK3	1.26e-04	11	276	3	DOID:5603 (is_implicated_in)
Disease	pars orbitalis volume measurement	SLIT2 CRACR2A FCRL5	1.26e-04	11	276	3	EFO_0010320
Disease	lipoprotein measurement, phospholipid measurement	PCSK9 MYO1H APOB LDLR LEPR ABCA6	1.49e-04	85	276	6	EFO_0004639, EFO_0004732
Disease	lipid measurement, lipoprotein measurement	PCSK9 APOB LDLR LEPR LLGL1 ABCA6	2.05e-04	90	276	6	EFO_0004529, EFO_0004732
Disease	esterified cholesterol measurement	PCSK9 APOB LDLR LEPR LLGL1 ABCA6 ANKRD17	2.09e-04	128	276	7	EFO_0008589
Disease	hematologic cancer (implicated_via_orthology)	TYK2 JAK1 JAK3	2.16e-04	13	276	3	DOID:2531 (implicated_via_orthology)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	PDZD7 DMXL2 TMEM132E	2.16e-04	13	276	3	C1846647
Disease	X-11478 measurement	ACSM2A ACSM2B	2.60e-04	3	276	2	EFO_0021242
Disease	Pasteurellaceae Infections	CP CRP	2.60e-04	3	276	2	C0085397
Disease	Respiratory Tract Infections	LEPR RPGR	2.60e-04	3	276	2	C0035243
Disease	Upper Respiratory Infections	LEPR RPGR	2.60e-04	3	276	2	C0041912
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB LDLR ANKRD17	2.73e-04	14	276	3	EFO_0004611, EFO_0008589
Disease	response to statin, LDL cholesterol change measurement	PCSK9 APOB LDLR	3.39e-04	15	276	3	EFO_0007804, GO_0036273
Disease	free cholesterol to total lipids in large VLDL percentage	PCSK9 APOB LDLR ABCA6	3.88e-04	37	276	4	EFO_0022281
Disease	level of Sterol ester (27:1/18:1) in blood serum	PCSK9 LDLR ANKRD17	4.14e-04	16	276	3	OBA_2045195
Disease	triglycerides to total lipids in large VLDL percentage	PCSK9 APOB LDLR ABCA6	4.76e-04	39	276	4	EFO_0022332
Disease	Hypercholesterolemia	ANGPTL3 PCSK9 APOB LDLR	4.76e-04	39	276	4	C0020443
Disease	Lipidemias	APOB LDLR LEPR	5.00e-04	17	276	3	C1706412
Disease	Hyperlipidemia	APOB LDLR LEPR	5.00e-04	17	276	3	C0020473
Disease	Hypereosinophilic syndrome	PDGFRA JAK1	5.17e-04	4	276	2	C1540912
Disease	unipolar depression, smoking behaviour measurement	OR5AK2 OR5AK3P	5.17e-04	4	276	2	EFO_0003761, EFO_0005671
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	LYST WDFY3	5.17e-04	4	276	2	DOID:2935 (implicated_via_orthology)
Disease	cholesterol in very small VLDL measurement	PCSK9 APOB LDLR ABCA6	5.25e-04	40	276	4	EFO_0022231
Disease	free cholesterol in medium LDL measurement	PCSK9 APOB LDLR ABCA6	5.25e-04	40	276	4	EFO_0022268
Disease	level of Sphingomyelin (d34:1) in blood serum	PCSK9 LDLR ANKRD17	5.95e-04	18	276	3	OBA_2045175
Disease	Hypercholesterolemia, Familial	PCSK9 APOB LDLR	5.95e-04	18	276	3	C0020445
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PCSK9 SEMA4D DNAH10 MYO1H APOB LDLR DNAH1 ABCA6	6.22e-04	200	276	8	EFO_0004611, EFO_0020945
Disease	Glioblastoma Multiforme	MYC LZTR1 PDGFRA TMEM135 IDH2 CDK3	6.32e-04	111	276	6	C1621958
Disease	free cholesterol to total lipids in very small VLDL percentage	PCSK9 APOB LDLR ABCA6	6.94e-04	43	276	4	EFO_0022290
Disease	free cholesterol measurement	PCSK9 APOB LDLR LEPR LLGL1 ABCA6	6.95e-04	113	276	6	EFO_0008591
Disease	concentration of large LDL particles measurement	PCSK9 APOB LDLR ABCA6	7.58e-04	44	276	4	EFO_0022160
Disease	cholesterol in medium VLDL measurement	PCSK9 APOB LDLR ABCA6	7.58e-04	44	276	4	EFO_0022225
Disease	Thromboembolism	OR51B5 DOCK8 CSMD1 OR51V1	7.58e-04	44	276	4	HP_0001907
Disease	total lipids in very small VLDL measurement	PCSK9 APOB LDLR ABCA6	8.25e-04	45	276	4	EFO_0022156
Disease	cholesterol to total lipids in large VLDL percentage	PCSK9 APOB LDLR ABCA6	8.25e-04	45	276	4	EFO_0022236
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	8.56e-04	5	276	2	EFO_0800378
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	PCSK9 APOB LDLR	9.50e-04	21	276	3	EFO_0022246
Disease	total lipids in small LDL	PCSK9 APOB LDLR ABCA6	9.74e-04	47	276	4	EFO_0022168
Disease	free cholesterol in small VLDL measurement	PCSK9 APOB LDLR ABCA6	9.74e-04	47	276	4	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	PCSK9 APOB LDLR ABCA6	9.74e-04	47	276	4	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	PCSK9 APOB LDLR ABCA6	9.74e-04	47	276	4	EFO_0022269
Disease	phospholipids in medium LDL measurement	PCSK9 APOB LDLR ABCA6	1.14e-03	49	276	4	EFO_0022183
Disease	apolipoprotein B to apolipoprotein A1 ratio	PCSK9 APOB LDLR ABCA6	1.14e-03	49	276	4	EFO_0021897
Disease	cholesterol in medium LDL measurement	PCSK9 APOB LDLR ABCA6	1.14e-03	49	276	4	EFO_0022224
Disease	cholesterol in small LDL measurement	PCSK9 APOB LDLR ABCA6	1.14e-03	49	276	4	EFO_0022227
Disease	cholesteryl esters to total lipids in small VLDL percentage	PCSK9 APOB LDLR ABCA6	1.14e-03	49	276	4	EFO_0022256
Disease	Medulloblastoma	MYC PDGFRA PMS2 PRAME	1.23e-03	50	276	4	C0025149
Disease	triglycerides to total lipids in medium LDL percentage	PCSK9 APOB LDLR ABCA6	1.23e-03	50	276	4	EFO_0022334
Disease	free cholesterol in LDL measurement	PCSK9 APOB LDLR ABCA6	1.23e-03	50	276	4	EFO_0022266
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	1.28e-03	6	276	2	EFO_0800106
Disease	acute promyelocytic leukemia (is_marker_for)	MYC PRAME	1.28e-03	6	276	2	DOID:0060318 (is_marker_for)
Disease	GLIOMA SUSCEPTIBILITY 1	LZTR1 IDH2	1.28e-03	6	276	2	C2750850
Disease	extraversion measurement	DAB2IP SLC23A2	1.28e-03	6	276	2	EFO_0007913
Disease	free cholesterol in large LDL measurement	PCSK9 APOB LDLR ABCA6	1.32e-03	51	276	4	EFO_0022176
Disease	phospholipids in very small VLDL measurement	PCSK9 APOB LDLR ABCA6	1.32e-03	51	276	4	EFO_0022300
Disease	Dyslipidemias	APOB LDLR LEPR	1.42e-03	24	276	3	C0242339
Disease	Dyslipoproteinemias	APOB LDLR LEPR	1.42e-03	24	276	3	C0598784
Disease	phospholipids in medium VLDL measurement	PCSK9 APOB LDLR ABCA6	1.42e-03	52	276	4	EFO_0022154
Disease	phospholipids in IDL measurement	PCSK9 APOB LDLR ABCA6	1.42e-03	52	276	4	EFO_0022164
Disease	total lipids in medium LDL	PCSK9 APOB LDLR ABCA6	1.42e-03	52	276	4	EFO_0022180
Disease	total lipids in LDL measurement	PCSK9 APOB LDLR ABCA6	1.42e-03	52	276	4	EFO_0022308
Disease	phospholipids in large LDL measurement	PCSK9 APOB LDLR ABCA6	1.53e-03	53	276	4	EFO_0022174
Disease	triglycerides to total lipids in very large VLDL percentage	PCSK9 APOB LDLR ABCA6	1.53e-03	53	276	4	EFO_0022340
Disease	cholesterol in small VLDL measurement	PCSK9 APOB LDLR ABCA6	1.53e-03	53	276	4	EFO_0022228
Disease	free cholesterol in small LDL measurement	PCSK9 APOB LDLR ABCA6	1.53e-03	53	276	4	EFO_0022271
Disease	cholesteryl esters to total lipids in very large VLDL percentage	PCSK9 APOB LDLR ABCA6	1.53e-03	53	276	4	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	PCSK9 APOB LDLR ABCA6	1.64e-03	54	276	4	EFO_0022244
Disease	level of Sterol ester (27:1/16:0) in blood serum	PCSK9 APOB LDLR	1.79e-03	26	276	3	OBA_2045191
Disease	macrophage inflammatory protein 1b measurement	TADA2A TOP3B NOL9 LRIG3 TMEM132E SLFN11	1.81e-03	136	276	6	EFO_0008219
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	PCSK9 APOB LDLR LLGL1 ABCA6 ANKRD17	1.88e-03	137	276	6	EFO_0004611, EFO_0008591
Disease	cholesterol to total lipids in large LDL percentage	PCSK9 APOB LDLR FITM2	1.88e-03	56	276	4	EFO_0022235
Disease	free cholesterol to total lipids in large HDL percentage	PCSK9 APOB LDLR ABCA6	1.88e-03	56	276	4	EFO_0022279
Disease	cholesteryl esters to total lipids in large VLDL percentage	PCSK9 APOB LDLR ABCA6	1.88e-03	56	276	4	EFO_0022250
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	PCSK9 APOB LDLR LLGL1 ABCA6	1.92e-03	94	276	5	EFO_0008595, EFO_0010351
Disease	total lipids in large LDL	PCSK9 APOB LDLR ABCA6	2.00e-03	57	276	4	EFO_0022163
Disease	cholesterol in large LDL measurement	PCSK9 APOB LDLR ABCA6	2.00e-03	57	276	4	EFO_0021901
Disease	Psoriasis	TYK2 CP CRP CSMD1	2.00e-03	57	276	4	C0033860
Disease	Pustulosis of Palms and Soles	TYK2 CP CRP CSMD1	2.00e-03	57	276	4	C0030246
Disease	lipid measurement, intermediate density lipoprotein measurement	PCSK9 APOB LDLR LLGL1 ABCA6	2.11e-03	96	276	5	EFO_0004529, EFO_0008595
Disease	cholesterol in IDL measurement	PCSK9 APOB LDLR ABCA6	2.14e-03	58	276	4	EFO_0021899
Disease	phospholipids in LDL measurement	PCSK9 APOB LDLR ABCA6	2.14e-03	58	276	4	EFO_0022294
Disease	phospholipids in small LDL measurement	PCSK9 APOB LDLR ABCA6	2.28e-03	59	276	4	EFO_0022297
Disease	free cholesterol to total lipids in very large VLDL percentage	PCSK9 APOB LDLR ABCA6	2.28e-03	59	276	4	EFO_0022289
Disease	inflammatory response	LEPR CRP	2.35e-03	8	276	2	GO_0006954
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	PCSK9 APOB LDLR LLGL1 ABCA6	2.42e-03	99	276	5	EFO_0004574, EFO_0008595
Disease	phospholipids in small VLDL measurement	PCSK9 APOB LDLR ABCA6	2.42e-03	60	276	4	EFO_0022146
Disease	total lipids in IDL	PCSK9 APOB LDLR ABCA6	2.42e-03	60	276	4	EFO_0022161
Disease	longitudinal BMI measurement, response to amisulpride	ADCY9 SLC29A4 KIF18B	2.47e-03	29	276	3	EFO_0005937, EFO_0010718
Disease	level of Sphingomyelin (d42:2) in blood serum	PCSK9 LDLR ANKRD17	2.47e-03	29	276	3	OBA_2045183
Disease	free cholesterol in IDL measurement	PCSK9 APOB LDLR ABCA6	2.57e-03	61	276	4	EFO_0022181
Disease	neurotic disorder	CTTNBP2 ZNF184 MMS22L MYO1H CSMD1	2.63e-03	101	276	5	EFO_0004257
Disease	triglycerides to total lipids in IDL percentage	PCSK9 APOB LDLR ABCA6	2.89e-03	63	276	4	EFO_0022329
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	PCSK9 APOB LDLR LLGL1 ABCA6	2.99e-03	104	276	5	EFO_0008591, EFO_0008595

Protein segments in the cluster

Peptide	Gene	Start	Entry
VDAGYCAASLHTSVV	URB2	286	Q14146
TFLSLVSHLAGYISC	nan	196	Q6ZRP5
VSHLAGYISCQFIFS	nan	201	Q6ZRP5
TCFQEHSSYGRNSLE	AZI2	331	Q9H6S1
DVRHSTYNSTCVGSL	CFAP54	2966	Q96N23
GCISHFTLSTDYHIS	EGFLAM	986	Q63HQ2
SGYTFSAVCFHSANS	ABRAXAS2	6	Q15018
SVTFACSGHTLLEYV	AQP12A	206	Q8IXF9
YTGSLFCVHVSNLVF	CATSPERD	146	Q86XM0
FTCNTGYTLVGSHVR	CSMD1	2646	Q96PZ7
TVSFSCDSGYRLSHE	CSMD3	1031	Q7Z407
GFQLVYTSFELSHCE	CSMD3	1341	Q7Z407
GHQVALSSISYVGCS	ADGRD1	561	Q6QNK2
CYLIGQHGASLSSFL	ALS2	746	Q96Q42
ATAVCHTDAYTLSGA	ADH5	41	P11766
GTINDFSYLHTNCLE	AEBP1	856	Q8IUX7
LAVFFSVIHSSYCIG	ABCB5	326	Q2M3G0
SYIQDHVCVSIATGS	ADAM18	571	Q9Y3Q7
ASSNPCSETYHGKFA	CPA1	266	P15085
HCVETGSQEASAIYF	ACSM2A	206	Q08AH3
ERHYSPLFFLNSSSC	ABCA6	426	Q8N139
CYTAHSGKLSAAEAQ	CD93	36	Q9NPY3
AQFHSGLYTEACFVL	POLE2	211	P56282
ECSAYSGHNTKESLL	CRACR2A	686	Q9BSW2
NSQVFHVYCDVISGS	ANGPTL3	266	Q9Y5C1
ASLSASIYQALCDSH	DMXL2	2261	Q8TDJ6
SIYQALCDSHSYSQT	DMXL2	2266	Q8TDJ6
SVTFACSGHTLLEYV	AQP12B	206	A6NM10
HATTATGDTALTYAC	ANKRD17	591	O75179
STGYLSDNIFTHFVA	SLC25A10	191	Q9UBX3
AFTCHDSGATVLAYA	DMXL1	2881	Q9Y485
SCLLHEFTISGTTYT	ATP2A3	376	Q93084
NVLIGHSYGVSFCTF	ABHD8	246	Q96I13
CALLYFTGSAHFNRS	POLL	501	Q9UGP5
SACSDIYGESISSHF	R3HCC1L	441	Q7Z5L2
EVACGSYHSLVLTSD	RCBTB2	156	O95199
CASHLTIVTLFYGTL	OR5M10	241	Q6IEU7
CASHFSSVSLFYGSI	OR5K2	241	Q8NHB8
TCASHLSVVSIFYGT	OR7A2P	241	Q8NGA2
ASRSSLCVNGSHIYN	RAB11FIP5	331	Q9BXF6
SFGVTLHELLTYCDS	JAK1	1066	P23458
VYHSLFALATEDLSC	JAK3	66	P52333
GIDHDACSYFTSNAL	PIK3C2G	886	O75747
AFSTCGAHLLSVSLY	OR5H8	236	P0DN80
CASHLSVVSLFYGAI	OR7A5	241	Q15622
VLSAAHCFQNSYTIG	KLK4	66	Q9Y5K2
YKLSTAGLFQTDCEH	LLGL1	471	Q15334
HINLQYSTISEFCTG	MOB2	66	Q70IA6
TEGTFNVECLTTDHY	CP	691	P00450
EVSSASAAHTGLYTC	PDGFRA	86	P16234
HSSILGQDYCFEVTT	DAB2IP	161	Q5VWQ8
PAQDIFSVYTHSCLS	NOL9	161	Q5SY16
FFLSHLSLVDICYSS	OR9Q2	61	Q8NGE9
FSTCGSHLTVVLLFY	OR1S1	251	Q8NH92
CSSHLIVVSLFYGTA	OR10A7	241	Q8NGE5
CASHLTSVTLFYGTA	OR10A3	241	P58181
NSHAISYAGCVSQLF	OR10D4P	86	Q8NGN7
CGSHLIVVSLFYSTA	OR2B6	241	P58173
FGTCSSHLTVVTLFY	OR2H2	236	O95918
TISFVGCTAQHFLYL	OR2T1	141	O43869
FATCSSHVAVVGLFY	OR2T12	236	Q8NG77
STCASHLTALSIFYG	OR5B21	236	A6NL26
IQNHVSSFSDCGLFT	MKKS	81	Q9NPJ1
FLSCYQTGASLVTHF	MDN1	3656	Q9NU22
DHSCSDSVEYLTLNF	LZTR1	31	Q8N653
ASSVAYCFTHLSLQE	NLRC3	446	Q7RTR2
ECGIHLYQESTSKSA	NLRC4	556	Q9NPP4
NDLSICGTLHSVDQY	LSM2	21	Q9Y333
SSFLHIGDICSLYAE	ITPR1	6	Q14643
CVISNHFGSSYSVKA	LRIG3	581	Q6UXM1
NTSLFAVATVHGLYC	DYNLT4	206	Q5JR98
ALHCLAVTDSGQVYA	HERC2	3266	O95714
TLCEALSHSGYVSFQ	MMS22L	796	Q6ZRQ5
VFDAGSSHTSLFLYQ	ENTPD8	46	Q5MY95
VLQANLSSAGHYSCI	HMCN2	2511	Q8NDA2
LSSAGHYSCIAANAV	HMCN2	2516	Q8NDA2
SNSLGRATVSHYECL	KIF26B	1666	Q2KJY2
CSGPVTHSSVDSYFL	LCORL	466	Q8N3X6
ISCRSSQSLLHSNGY	IGKV2D-28	41	P01615
FYTHTACDANGETQL	ELAPOR1	336	Q6UXG2
SLNTRAYHCFSAGLS	DCAF4L1	191	Q3SXM0
TCVVYSHDGTELLAS	DCAF8L2	426	P0C7V8
NTLTSFCGALHTSFV	GRIA3	111	P42263
TSHVLGAYAVDNTCV	PCSK9	641	Q8NBP7
NLSLTAEHSGNYSCE	FCRL5	621	Q96RD9
NLSLTAEHSGNYSCE	FCRL5	806	Q96RD9
ENYDSCYSQTLSLHG	LRRC36	331	Q1X8D7
LSFHGRQSSYCSNTF	MMP19	156	Q99542
AAVLSFSYCSSLEIH	OR2M4	161	Q96R27
ATCSSHLTVVILFYG	OR2T4	271	Q8NH00
SSVGCFLQAYFIHSL	OR51B2	91	Q9Y5P1
GSAACFSQAYFIHSL	OR51B5	91	Q9H339
FATCSSHVAVVGLFY	OR2T8	236	A6NH00
TCSSHLTAVTLFYGA	OR2V1	241	Q8NHB1
TCSSHLTAVTLFYGA	OR2V2	241	Q96R30
CGSHLTVVSLFYGNI	OR2W3	241	Q7Z3T1
TCSSHLIVVSLFYGT	OR2W6P	246	Q8NHA6
ASIQTSITLHFPYCA	OR2Z1	156	Q8NG97
FSTCGSHLTVVAIFY	OR3A1	241	P47881
ISLDSCIAQSYFIHG	OR51V1	101	Q9H2C8
FSTCSSHLTVVGIFY	OR3A4P	241	P47883
YSLVSEFVLHGLCTS	OR4K14	6	Q8NGD5
TCASHLTAVTLFYGS	OR5A2	241	Q8NGI9
SYLCGFLNASIHTGD	OR5B3	146	Q8NH48
LSTCASHFIAVGIFY	OR5B3	236	Q8NH48
SSAYSYSLERHVCLG	PDPR	801	Q8NCN5
VHLYTTSDDFCLGFN	PDZD7	211	Q9H5P4
LATAFSIYCGISIAH	PDE2A	536	O00408
SIHVSQSGVIYCRDS	PDE8B	6	O95263
SKANITCLVYSHDGT	DCAF8	386	Q5TAQ9
TCLVYSHDGTELLAS	DCAF8	391	Q5TAQ9
HSCGFISTTRDILYS	ZFPM1	351	Q8IX07
SCGSEENHSYTLSLE	RASGRP4	616	Q8TDF6
TLDTHTLSLTDYACG	HOXA9	146	P31269
FALEVYTFTGSSCLH	DNAJC16	641	Q9Y2G8
LDQSVSSHLGIGCSY	MYRFL	131	Q96LU7
AHSAAVTASGDCYTF	NEK8	571	Q86SG6
FLETTAAQLTYHGLC	MINDY1	286	Q8N5J2
LTSVGSNVSFHCIYK	LEPR	341	P48357
ISTENYHTLGCLSLV	KNTC1	196	P50748
IDLGTTYSCVGVFQH	HSPA1L	11	P34931
LTGCYADQHSVQVFA	AP5M1	441	Q9H0R1
AQGYHISPSSSSLFC	LAMA5	1406	O15230
AISFAGCTAQHFLYL	OR2T27	91	Q8NH04
FATCSSHVAVVGLFY	OR2T33	236	Q8NG76
TCSSHVAVVSLFYGS	OR2C3	241	Q8N628
YHVFRGISEIQSCSD	PAPPA	571	Q13219
QEALSTSHGYHLFCA	PAQR6	216	Q6TCH4
CSSHVIALSLFFGSA	OR8B3	241	Q8NGG8
FSTCGSHLTAVIIFY	OR5M3	236	Q8NGP4
CASHLTAVTIFYGTL	OR5J2	241	Q8NH18
DSQYTHLAFGCILSE	PRSS54	61	Q6PEW0
RAICSSTQAGSFHFT	MROH1	801	Q8NDA8
TGVHESLTCQVFGYI	GPR52	106	Q9Y2T5
HSVLDSFLQGYNCSV	KIF18B	91	Q86Y91
SYSGTFHSLEEQQVC	NBPF1	851	Q3BBV0
LAHCTGSATSYELTQ	IGLV3-12	11	A0A075B6K2
GTSVSIECLLTASHY	MFAP3	66	P55082
DLCTQLFHGSLAFTY	OXER1	331	Q8TDS5
CASHFLSVSLFYGSL	OR5K1	241	Q8NHB7
CHLDSNGLYSRSTEF	ITGB7	311	P26010
CASHLTAVTIFYGTL	OR5AK3P	241	Q8NH89
TCGSHLAVVSLFYGT	OR1K1	241	Q8NGR3
CGSHLTVVTLFYGSI	OR1L1	291	Q8NH94
FSTCGSHLTIALLFY	OR1S2	251	Q8NGQ3
SISFVGCATQHFLYL	OR2AE1	91	Q8NHA4
FLSHLSFLDLCYTTT	OR2B11	66	Q5JQS5
CSSHITVVSLFYGAA	OR2T10	241	Q8NGZ9
EYSCEAGSQRLSFHL	OBSCN	1511	Q5VST9
CSAHLLSVSLFYGTL	OR5AC1	241	P0C628
STCGAHLLSVSLYYG	OR5AC2	241	Q9NZP5
FSTCGSHLTLVFIGY	OR6V1	236	Q8N148
TCTSHLTVVTLFYGT	OR5P2	236	Q8WZ92
CASHLAIVFLFYGSA	OR5V1	241	Q9UGF6
CSSQSSFDIYHLSRE	KIR2DL4	146	Q99706
CASHLTAVTIFYGTL	OR5AK2	241	Q8NH90
HYLNTSGASCESRII	KCTD18	146	Q6PI47
GASCVSLLTLSHYSE	NLGN4Y	256	Q8NFZ3
HTVATFSLSFCGSNE	OR5T1	171	Q8NG75
SYLFQLLQGVSFCHS	CDK3	106	Q00526
SYSSLGEDFLNSCHK	DNAH1	3796	Q9P2D7
FSLALIITTISHCGY	FAXDC2	251	Q96IV6
VLFLDTVYGNCSTHF	APOB	176	P04114
YNCSLLDGTQLFTSH	FKBP10	406	Q96AY3
YLAVSASRNVHSSGC	FAM126A	86	Q9BYI3
TSFSTFLVCNIDYGH	IGSF10	356	Q6WRI0
ESISGFAHSCFQYAI	IDH2	226	P48735
CDQSTTYLTHCFATL	DOCK8	1471	Q8NF50
EEAAHQGCLTSSYLL	CCNF	211	P41002
SALYSAAKNGHTDCV	CTTNBP2	746	Q8WZ74
ICTSIFSNIEHYTGS	FITM2	106	Q8N6M3
YFTSVLNSHEPLCSV	BATF	81	Q16520
SESVYSGCLHLVSDL	C1orf112	106	Q9NSG2
CFLVLTSLSHAFGQT	CRP	6	P02741
CDNHASSEQLYFSTP	DUSP7	391	Q16829
VFTGSAALIAVVHYC	ADCY9	896	O60503
INLFLPTDSSHYFSC	DUXB	186	A0A1W2PPF3
AVTIHACSSSGSQYF	LYST	2506	Q99698
SLTFSCDGHHLYTAN	LYST	3756	Q99698
NLSLTTEHSGNYSCE	FCRL3	531	Q96P31
HTAANFGLYCFVSKT	GPR142	406	Q7Z601
YIVCDFHSLSGFTSS	ERAP2	266	Q6P179
VQKSAYGFHTASSCF	DYNLT3	71	P51808
ISCRSSQSLLHSNGY	IGKV2-28	41	A0A075B6P5
CSDLAVSFHYVDSTT	C1GALT1	301	Q9NS00
HSILVNGATDYCSLS	EPS15	516	P42566
LFLSLSGCYQITDHG	FBXL5	601	Q9UKA1
DGSCAVYTFHVFSSL	FRY	2696	Q5TBA9
LSLTAEHSGNYSCEA	FCRL2	356	Q96LA5
CSGSSYFVLANGHIL	FMR1NB	91	Q8N0W7
TLTFSIYNHGCTGLF	DNAH10	3706	Q8IVF4
HISDAGTYTCLATNS	SDK2	466	Q58EX2
YCSKVFGTDSSLQIH	SALL4	386	Q9UJQ4
GDSACFTLSLLGHVY	CDC27	111	P30260
HLNFYCSLFSAAGSL	MFSD13A	161	Q14CX5
GASCVSLLTLSHYSE	NLGN4X	256	Q8N0W4
AGDRSFCQILYDHST	DCAF15	261	Q66K64
SIALTHSIYSCSNLF	MS4A13	121	Q5J8X5
AFSTCGSHLSVVSLF	OR1E2	246	P47887
FSTCGSHLAVVSLFY	OR11G2	276	Q8NGC1
CAAHLTSVTLFYGTA	OR10A6	241	Q8NH74
CGSHLAVVSLCYSSL	OR11H1	256	Q8NG94
CGSHLAVVSLCYSSL	OR11H12	256	B2RN74
SSHLCVVGLFYGTAI	OR2A25	241	A4D2G3
CGSHLTVVSLFYGTA	OR2B8P	241	P59922
CGSHLIVVSLFYGTA	OR2B2	241	Q9GZK3
CFSHLAAVSILYGTL	OR5G3	241	P0C626
AGYFVDATTITECLH	PCGF1	51	Q9BSM1
CSSHVIALSLFFGSA	OR8B2	241	Q96RD0
QYLSLHVSLNFSCGT	OR9A2	91	Q8NGT5
AFSTCGSHLSVVSLF	OR7C2	236	O60412
VDCETYHTAASTLGS	MED20	41	Q9H944
AFSTCGSHLTVVSLY	OR1A1	236	Q9P1Q5
CASHLGVVSLFYGTL	OR1D4	241	P47884
CASHLGVVSLFYGTL	OR1D5	241	P58170
CGSHLSVVSLFYGTV	OR1E1	241	P30953
CSSHLTVVILFYGSI	OR1L3	241	Q8NH93
TCGSHLTVVVLFYGS	OR1L4	241	Q8NGR5
STCGSHLTAVALFYG	OR1L6	276	Q8NGR2
CSSHLSVVALFYGTT	OR1M1	241	Q8NGA1
STCGSHLTVVLLFYG	OR1N2	256	Q8NGR9
STCSAHSIVVILFYG	OR13D1	271	Q8NGV5
FGTCSSHLTVVTLFY	OR2H1	236	Q9GZK4
AFSTCGAHLTVVILY	OR2K2	236	Q8NGT1
TISYISCGENHTALI	RPGR	296	Q92834
YTLFRCLLNTSNHSG	GLMN	401	Q92990
TQLTYHGLCELTSTV	MINDY2	421	Q8NBR6
ETQLCLYCSQSGHFT	RTL4	276	Q6ZR62
SIAFYNVSDGCHINT	RFPL4AL1	226	F8VTS6
AAHCFSGSLNSSDYQ	TPSG1	76	Q9NRR2
HLNFYCTGSSLGNLI	RAP1GAP2	166	Q684P5
AGATYTCQVTHISLE	TAPBPL	376	Q9BX59
SDQGLYHCIATENSF	SEMA3C	636	Q99985
TCNSTFLHLDTQGCY	SSPOP	4346	A2VEC9
SLSHCSQLTTLSFYG	PRAME	401	P78395
SASRGCTLQYQHATL	TMEM132E	581	Q6IEE7
TAGITNFCSARTYDH	TADA2A	291	O75478
RGHSVCSTSSLYLQD	MYC	166	P01106
FSTCGSHLAVVCLFY	OR7E24	256	Q6IFN5
CASHLSVVSLFYGTC	OR7A10	241	O76100
CASHLTIVTLFYGTL	OR5M1	241	Q8NGP8
YSAHFVGNCLIVTSL	NBEA	291	Q8NFP9
PGNSVYHFDKSTSSC	SETD7	186	Q8WTS6
LTALHTCDQVSAYGF	ST6GALNAC2	311	Q9UJ37
SSCVVVHNQYIGADF	SHOC1	791	Q5VXU9
FLDYFQTSHLDCSGL	SLFN11	701	Q7Z7L1
HYSQLTQFTCETTLD	SSPN	146	Q14714
AFSTCGSHLTAVTIF	OR5M8	236	Q8NGP6
ILYNGVDVTFHTSFC	PXYLP1	421	Q8TE99
YQDVSCLQFTGDSSH	WDR18	121	Q9BV38
DPATLYCINFSHDSS	WDR45	236	Q9Y484
VCTHSSYQEGTTLAF	SI	861	P14410
CAYNLSTAEEVFSHG	SEMA4D	326	Q92854
LGTCFSSSYQDLAKH	STARD9	4476	Q9P2P6
YFGSLTALVCQHSIT	TNS3	1256	Q68CZ2
LVAHTTLTFSLSYCG	OR5AR1	156	Q8NGP9
CTSHLTAVTLFYGTI	OR5P3	241	Q8WZ94
FGDSTCGQRAIYHSL	SCP2	66	P22307
TIHTVATFSLSFCGA	OR5T2	196	Q8NGG2
VFSTCGAHLTGVSIY	OR5T2	276	Q8NGG2
DANSCHSFQSAYLIV	SCRN1	146	Q12765
TSYTECLNGAQSLHR	SPTBN5	1546	Q9NRC6
CDTEYFTQTLAQLSH	SMCR8	326	Q8TEV9
HCVETGSQEASAIYF	ACSM2B	206	Q68CK6
SGTQHAGDFICTVYL	ARAP1	1166	Q96P48
LGLTQYHVSERSFAC	AQP11	141	Q8NBQ7
STAGVFLSTLHCQDY	NCAPH	256	Q15003
YGILCLQAHSASVTA	C12orf76	116	Q8N812
DCGKTFSQTSSLVYH	ZNF845	471	Q96IR2
SSFLECHGVVNVTAY	TECTA	921	O75443
FIATVSHDCKYLQST	TOP3B	416	O95985
CGDSFALEKSLTQHY	ZNF532	621	Q9HCE3
ECGKAFSVSSALIYH	ZNF735	301	P0CB33
TTAAGEAFYTLVCLH	XPO4	1071	Q9C0E2
GTASEVYQSTEILHC	ERVK-24	56	P63129
TCATASLAYHIIVSG	WDFY3	3131	Q8IZQ1
IYLSSHCATTFKEDG	ZDHHC13	491	Q8IUH4
CSLDAETSSRTHFYA	SEMA4G	306	Q9NTN9
EGHSLAQTVFTCLYI	NAA35	121	Q5VZE5
GCFVRSLSTVYSNTH	SPATA12	171	Q7Z6I5
GLQHYLTCFSGTIAV	SLC23A2	106	Q9UGH3
LRCGAASTQYHDIST	TBC1D8B	386	Q0IIM8
FQYHSLDVTGFLLAC	UGT2B4	486	P06133
SHRELSQTFCGSTAY	TSSK3	161	Q96PN8
NTLSGFCFVTFTEHS	PWP2	401	Q15269
KAFTALCYSADGHSI	PWP2	606	Q15269
NCTVFYPSDAISTEH	TKTL2	446	Q9H0I9
CGRTFSQSSSLIVHY	ZNF514	321	Q96K75
VAVGSSYFHACLSKN	ZBTB41	106	Q5SVQ8
GTASEVYQSTEILHC	ERVK-7	56	P63131
LDCASAIQNYLSGTH	UNC5CL	481	Q8IV45
GTASEVYQSTEILHC	ERVK-6	56	Q9Y6I0
HADTIIYSISTAICF	TMEM135	376	Q86UB9
GTASEVYQSTEILHC	ERVK-25	56	P63125
AHTSLVDNYGSSCSE	ZDBF2	566	Q9HCK1
CTFIGNQDTYETHLE	TRAF7	266	Q6Q0C0
SLTECSAHAAYLAAV	TLNRD1	121	Q9H1K6
HSSDFIELCLYTLGN	TMCO6	161	Q96DC7
YNCGDLSSVILSHDS	TRABD2A	256	Q86V40
GTSFHGCIRNLYINS	SLIT2	1301	O94813
CHVLLDSFGTYALTG	UNC5D	666	Q6UXZ4
GLSCSDALHNLFYIS	PMS2	256	P54278
LFYISGFISQCTHGV	PMS2	266	P54278
HVSNKYGTDFICSSL	ZNF415	236	Q09FC8
DCKDYGNLFSHSVSL	ZNF544	271	Q6NX49
VAYCTYSLTRDAHGS	SLC29A4	501	Q7RTT9
SRFDAGTYTCTTLEH	SEMA3G	646	Q9NS98
GYHTTVFGVFSDCLL	TRAPPC9	661	Q96Q05
YISAVQAAHLGTLCS	UBR4	1261	Q5T4S7
SSCYLHSLPDLFNST	TTLL4	101	Q14679
ETAFHSACTYGKSID	TNNI3K	306	Q59H18
CYHTFLTFVLGTGNV	TTC39A	281	Q5SRH9
CGKAFYSPSSLQTHE	ZNF433	371	Q8N7K0
CSALGAEDNYTLVSH	MARS1	566	P56192
VSVSELLLYSSHQGC	UHMK1	116	Q8TAS1
GTASEVYQSTEILHC	ERVK-21	56	P63119
HECGKTFSYGSSLIQ	ZNF184	561	Q99676
DCGKAFSQSSSLIYH	ZNF7	501	P17097
TSGEHTCQVTSFLAF	TTI1	596	O43156
SFGVTLYELLTHCDS	TYK2	1086	P29597
ITINCSYSVGISALH	TRAV41	41	A0A0B4J266
GTASEVYQSTEILHC	HERV-K104	56	P63124
VYAALTSFHDVLCLG	VN1R2	261	Q8NFZ6
GTASEVYQSTEILHC	ERVK-19	56	P63120
TATYFQGVRLDNCHS	AGL	516	P35573
ICSTQLDRAHGVSSY	LDLR	451	P01130
YLSQGHCAKESSISD	MYO1H	231	Q8N1T3
ALKHYVESASSQSGC	NECAB1	271	Q8N987